CONMED director exercises 668 RSUs, gains new grant
CONMED Corp director David M. Bronson reported compensation-related equity activity.
Rhea-AI Filing Summary
CONMED Corp director David M. Bronson reported compensation-related equity activity. On June 2, 2026, he exercised 668 restricted stock units into the same number of common shares, bringing his direct common stock holdings to 17,909 shares.
On June 1, 2026, he received a new award of 5,772 RSUs under CONMED’s 2025 Long-Term Incentive Plan. Each RSU represents a contingent right to one share of common stock and generally vests 100% after one year. These transactions are reported as grants and derivative exercises rather than open-market buys or sells.
Positive
- None.
Negative
- None.
Insider Trade Summary
668 shares exercised/converted
Exercise
3 txns
Insider
Bronson David M.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | RSUs (Restricted Stock Units) | 668 | $0.00 | $0.00 |
| Exercise | Common Stock | 668 | $0.00 | $0.00 |
| Grant/Award | RSUs (Restricted Stock Units) | 5,772 | $0.00 | $0.00 |
Holdings After Transaction:
RSUs (Restricted Stock Units) — 5,772 contracts (Direct);
Common Stock — 17,909 shares (Direct)
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
Key Figures
RSUs exercised: 668 shares
RSU grant size: 5,772 RSUs
Shares owned after transactions: 17,909 shares
+2 more
5 metrics
RSUs exercised
668 shares
Common stock received from RSU exercise on June 2, 2026
RSU grant size
5,772 RSUs
New award on June 1, 2026 under 2025 Long-Term Incentive Plan
Shares owned after transactions
17,909 shares
Direct common stock holdings following June 2, 2026 exercise
RSU vesting schedule
100% after one year
Applies to RSUs under 2025 Long-Term Incentive Plan
RSU expiration dates
2035 and 2036
Expiration for exercised 668 RSUs and new 5,772 RSU award
Key Terms
Restricted Stock Units, 2025 Long-Term Incentive Plan, derivative security, grant, award, or other acquisition
4 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2025 Long-Term Incentive Plan financial
"will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity transactions did CONMED (CNMD) director David M. Bronson report?
David M. Bronson reported exercising 668 restricted stock units into common stock and receiving a new grant of 5,772 RSUs. Both actions are compensation-related, recorded as a derivative exercise and an equity award rather than open-market buying or selling.
What are the terms of David M. Bronson’s new 5,772 RSU award at CONMED (CNMD)?
The 5,772 RSUs awarded to David M. Bronson each represent a contingent right to receive one CONMED common share. They are granted under the 2025 Long-Term Incentive Plan and are generally scheduled to vest 100% after a one-year period from the grant date.
Are David M. Bronson’s recent CONMED (CNMD) transactions open-market stock purchases or sales?
The reported transactions are not open-market trades. They include a derivative exercise of 668 restricted stock units into common shares and a grant of 5,772 RSUs, both coded as compensation-related awards and exercises rather than market purchases or sales.
When do David M. Bronson’s reported CONMED (CNMD) RSUs vest and expire?
The new 5,772 RSUs generally vest 100% after one year under the 2025 Long-Term Incentive Plan. An exercised RSU block of 668 units previously had an expiration date in 2035, while the new RSU award carries an expiration date in 2036 according to the filing data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
